These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28238037)

  • 41. Computational studies of new potential antimalarial compounds--stereoelectronic complementarity with the receptor.
    Portela C; Afonso CM; Pinto MM; Ramos MJ
    J Comput Aided Mol Des; 2003 Sep; 17(9):583-95. PubMed ID: 14713190
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Calorimetry and thermodynamics in drug design.
    Chaires JB
    Annu Rev Biophys; 2008; 37():135-51. PubMed ID: 18573076
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Depsipeptides from microorganisms: a new class of antimalarials.
    Fotie J; Morgan RE
    Mini Rev Med Chem; 2008 Oct; 8(11):1088-94. PubMed ID: 18855725
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Drug discovery studies on quinoline-based derivatives as potential antimalarial agents.
    Sharma R; Patil S; Maurya P
    SAR QSAR Environ Res; 2014; 25(3):189-203. PubMed ID: 24601770
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Application of reverse docking for target prediction of marine compounds with anti-tumor activity.
    Chen F; Wang Z; Wang C; Xu Q; Liang J; Xu X; Yang J; Wang C; Jiang T; Yu R
    J Mol Graph Model; 2017 Oct; 77():372-377. PubMed ID: 28950183
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 2D, 3D-QSAR and molecular docking of 4(1H)-quinolones analogues with antimalarial activities.
    Jiménez Villalobos TP; Gaitán Ibarra R; Montalvo Acosta JJ
    J Mol Graph Model; 2013 Nov; 46():105-24. PubMed ID: 24185373
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New heterocyclic hybrids of pyrazole and its bioisosteres: design, synthesis and biological evaluation as dual acting antimalarial-antileishmanial agents.
    Bekhit AA; Hassan AM; Abd El Razik HA; El-Miligy MM; El-Agroudy EJ; Bekhit Ael-D
    Eur J Med Chem; 2015 Apr; 94():30-44. PubMed ID: 25768697
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Discovery of New Compounds Active against Plasmodium falciparum by High Throughput Screening of Microbial Natural Products.
    Pérez-Moreno G; Cantizani J; Sánchez-Carrasco P; Ruiz-Pérez LM; Martín J; El Aouad N; Pérez-Victoria I; Tormo JR; González-Menendez V; González I; de Pedro N; Reyes F; Genilloud O; Vicente F; González-Pacanowska D
    PLoS One; 2016; 11(1):e0145812. PubMed ID: 26735308
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Natural products in drug discovery: present status and perspectives.
    Molinari G
    Adv Exp Med Biol; 2009; 655():13-27. PubMed ID: 20047031
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hybrid molecules incorporating natural products: applications in cancer therapy, neurodegenerative disorders and beyond.
    Decker M
    Curr Med Chem; 2011; 18(10):1464-75. PubMed ID: 21428895
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Natural products as leads to potential drugs: an old process or the new hope for drug discovery?
    Newman DJ
    J Med Chem; 2008 May; 51(9):2589-99. PubMed ID: 18393402
    [No Abstract]   [Full Text] [Related]  

  • 52. Structural genomics and the metabolome: combining computational and NMR methods to identify target ligands.
    Parsons L; Orban J
    Curr Opin Drug Discov Devel; 2004 Jan; 7(1):62-8. PubMed ID: 14982149
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recent Advances in Molecular Docking for the Research and Discovery of Potential Marine Drugs.
    Chen G; Seukep AJ; Guo M
    Mar Drugs; 2020 Oct; 18(11):. PubMed ID: 33143025
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Computational identification of bioactive natural products by structure activity relationship.
    Zhou X; Li Y; Chen X
    J Mol Graph Model; 2010 Aug; 29(1):38-45. PubMed ID: 20488738
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The medicinal chemist's toolbox: an analysis of reactions used in the pursuit of drug candidates.
    Roughley SD; Jordan AM
    J Med Chem; 2011 May; 54(10):3451-79. PubMed ID: 21504168
    [No Abstract]   [Full Text] [Related]  

  • 56. Design of new plasmepsin inhibitors: a virtual high throughput screening approach on the EGEE grid.
    Kasam V; Zimmermann M; Maass A; Schwichtenberg H; Wolf A; Jacq N; Breton V; Hofmann-Apitius M
    J Chem Inf Model; 2007; 47(5):1818-28. PubMed ID: 17727268
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Emerging chemical patterns: a new methodology for molecular classification and compound selection.
    Auer J; Bajorath J
    J Chem Inf Model; 2006; 46(6):2502-14. PubMed ID: 17125191
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Physics-based methods for studying protein-ligand interactions.
    Huang N; Jacobson MP
    Curr Opin Drug Discov Devel; 2007 May; 10(3):325-31. PubMed ID: 17554859
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cheminformatic Insight into the Differences between Terrestrial and Marine Originated Natural Products.
    Shang J; Hu B; Wang J; Zhu F; Kang Y; Li D; Sun H; Kong DX; Hou T
    J Chem Inf Model; 2018 Jun; 58(6):1182-1193. PubMed ID: 29792805
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ranking poses in structure-based lead discovery and optimization: current trends in scoring function development.
    Rajamani R; Good AC
    Curr Opin Drug Discov Devel; 2007 May; 10(3):308-15. PubMed ID: 17554857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.